Cytoplasmic Bkca Channel Intron-Containing Mrnas Contribute to the Intrinsic Excitability of Hippocampal Neurons

Total Page:16

File Type:pdf, Size:1020Kb

Cytoplasmic Bkca Channel Intron-Containing Mrnas Contribute to the Intrinsic Excitability of Hippocampal Neurons Cytoplasmic BKCa channel intron-containing mRNAs contribute to the intrinsic excitability of hippocampal neurons Thomas J. Bell*, Kevin Y. Miyashiro*, Jai-Yoon Sul*†, Ronald McCullough‡, Peter T. Buckley*§, Jeanine Jochems*, David F. Meaney¶, Phil Haydon†, Charles Cantorʈ**, Thomas D. Parsons††‡‡, and James Eberwine*§** §Penn Genome Frontiers Institute, and Departments of *Pharmacology, †Neuroscience, ¶Bioengineering, and ††Otorhinolaryngology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104; ‡Program of Molecular and Cellular Biology and Biochemistry, Boston University, Boston, MA 02215; ʈSequenom, Inc., 3595 John Hopkins Court, San Diego, CA 92121; and ‡‡Department of Clinical Studies, New Bolton Center, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, PA 19348 Contributed by Charles Cantor, December 17, 2007 (sent for review December 5, 2007) -High single-channel conductance K؉ channels, which respond is not fully resolved, but the expression and subcellular distri jointly to membrane depolarization and micromolar concentra- bution patterns of splice variants are expected to be one func- tions of intracellular Ca2؉ ions, arise from extensive cell-specific tionally significant factor in determining their characteristic alternative splicing of pore-forming ␣-subunit mRNAs. Here, we input–output properties. Indeed, there is some evidence for ϩ report the discovery of an endogenous BKCa channel ␣-subunit members of the K channel family, for example BKCa (12) or intron-containing mRNA in the cytoplasm of hippocampal neurons. A-type (13), establishing functional gradients within the den- This partially processed mRNA, which comprises Ϸ10% of the total dritic processes of mature neurons, where they transform the BKCa channel ␣-subunit mRNAs, is distributed in a gradient shape of local synaptic potentials or the size of somatic action throughout the somatodendritic space. We selectively reduced potentials (14). endogenous cytoplasmic levels of this intron-containing transcript Here we report a novel form of posttranscriptional gene by RNA interference without altering levels of the mature splice expression (cytoplasmic splicing of a RNA with a retained forms of the BKCa channel mRNAs. In doing so, we could demon- intron) that plays a role in generating local populations of BKCa strate that changes in a unique BKCa channel ␣-subunit intron- channel mRNAs and proteins in hippocampal neurons. These containing splice variant mRNA can greatly impact the distribution results show that the regulation of a cytoplasmic BKCa channel of the BKCa channel protein to dendritic spines and intrinsic firing intron-containing mRNAs partially underlie the characteristic properties of hippocampal neurons. These data suggest a new input–output properties of hippocampal neurons. regulatory mechanism for modulating the membrane properties and ion channel gradients of hippocampal neurons. Results BKCa Channel Intron-Containing mRNAs Are Present in Hippocampal dendrite ͉ epilepsy ͉ intron-retention ͉ KCNMA1 ͉ local splicing Dendrites. To determine the repertoire of mRNA splice variants in the postsynaptic compartment, we prepared a cDNA template derived from antisense RNA amplification of polyA mRNA n mammalian neurons, the firing of an action potential re- isolated from rat hippocampal dendrites, which were harvested quires the coordinated gating of at least a dozen different I from 14- to 21-day-old cultures in vitro (15). Dendrites were classes of voltage-gated ion channels. The integration of these carefully harvested individually to ensure that no cell bodies, and currents manifests itself as characteristic input–output proper- thus nuclei, of any neuron or nonneuronal cell were harvested. ties intrinsic to each neuron. One such firing property of some From this starting material, we detected two separate PCR neurons, such as those in the hippocampus (1, 2) or cerebellum products using primers specific to intron 16 of KCNMA1 [sup- (3), is the ability to initiate repetitive burst firing in response to porting information (SI) Fig. 5a]. Intron 16 (i16) is Ϸ6,000 nt depolarizing current. Voltage-clamp analysis suggests that the long and lies upstream of a previously described ‘‘hot spot’’ for small net inward current that drives the depolarizing momentum alternative exon usage (16). Exons surrounding i16 encode the is a result of a subtle balance of the sum of inward and outward 3Ј-end of the first of two highly conserved Ca2ϩ-binding RCK postspike currents (4). Although short-term and long-term (regulators of conductance Kϩ channel) domains and the non- feedback mechanisms exist to preserve burst firing (5), it is conserved linker region spanning the first and second RCK known that relatively small changes in the size of an individual module (17) (see Fig. 1a). The nucleotide sequence of the PCR current may have a dramatic impact on firing activity (6). products (330 and 390 nt) proved to be identical to the rat One transient current activated during the falling phase of the genomic BKCa channel genomic DNA sequence deposited in action potential is the BKCa channel. In the central nervous GenBank. We also observed the presence and absence of introns system, BKCa channels are localized to the cell soma as well as in other mRNAs in amplified polyA mRNA dendrite samples the pre- and postsynaptic terminals of neurons, where they regulate fundamental neuronal functions such as burst firing, neurotransmitter release, shaping action potential waveforms, Author contributions: T.J.B. and K.Y.M. contributed equally to this work; T.J.B., K.Y.M., and frequency tuning (7). Native channels are assembled as J.-Y.S., R.M., P.T.B., C.C., T.D.P., and J.E. designed research; T.J.B., K.Y.M., J.-Y.S., R.M., P.T.B., tetramers of the pore-forming ␣-subunits encoded by a single and J.J. performed research; T.J.B., K.Y.M., J.-Y.S., R.M., P.T.B., D.F.M., P.H., C.C., and J.E. contributed new reagents/analytic tools; T.J.B., K.Y.M., J.-Y.S., R.M., P.T.B., C.C., T.D.P., and gene, KCNMA1 (8), which is subject to vast tissue-specific (9) J.E. analyzed data; and T.J.B., K.Y.M., J.-Y.S., R.M., P.T.B., J.J., D.F.M., P.H., C.C., T.D.P., and and cell-specific alternative splicing (10). The resulting func- J.E. wrote the paper. tional heterogeneity in BKCa channel currents is due in part to The authors declare no conflict of interest. 2ϩ these splicing events generating BKCa channels with altered Ca **To whom correspondence may be addressed. E-mail: [email protected] or sensitivity and gating kinetics (7) as well as altered channel [email protected]. trafficking (11). Channel differences also arise from modulation This article contains supporting information online at www.pnas.org/cgi/content/full/ via a family of tissue-specific auxiliary ␤-subunits (10). Cur- 0711796105/DC1. CELL BIOLOGY rently, the functional diversity among BKCa channels in neurons © 2008 by The National Academy of Sciences of the USA www.pnas.org͞cgi͞doi͞10.1073͞pnas.0711796105 PNAS ͉ February 12, 2008 ͉ vol. 105 ͉ no. 6 ͉ 1901–1906 Downloaded by guest on October 1, 2021 products. The i16-containing transcript represented 10.3% Ϯ 2.3% of the total BKCa channel transcript population (Fig. 1a). The levels of i16-containing transcripts reported here are in agreement with a previous study showing other KCNMA1 splice variants typically represent a small subset (Ϸ10%) of the total KCNMA1 transcript population (19). We next determined the endogenous KCNMA1 exonic com- bination between i16 to e18 in both hippocampal tissue and isolated dendrites. This region consists of four downstream exons: two constitutive exons (e17 and e18) and two alternatively spliced exons (e17a and e17b). Here we amplified cDNA with two sets of PCR primers: (i) e16 forward and e18 reverse to capture ‘‘all BKCa channel transcripts’’ or (ii) i16–1 forward and e18 reverse to capture ‘‘only i16-containg transcripts’’ (Fig. 1a). The PCR products were simultaneously assayed with the two different extension primers (XP2 and XP3) to capture all four exonic combinations (Fig. 1a). In the ‘‘all BKCa channel tran- scripts’’ population, every exonic combination was detected, but two highly abundant variants, e17–e18 and e17–e17a–e18, made up the bulk of the BKCa channel transcript population (Fig. 1a). A remarkably different pattern of splicing was detected in the ‘‘only i16-containing transcript’’ population. Unexpectedly, only one splice variant was detected; all of the i16-containing tran- scripts skip e17a and e17b and splice e17 directly to e18 (Fig. 1a). These data show that i16-containing mRNAs are restricted to a subset of the KCNMA1 transcript population containing cor- rectly spliced downstream exons, e17 and e18. Furthermore, Fig. 1. BKCa channel intron-containing mRNAs are present in the cytoplasm these results highlight two key properties of i16-contiaining of hippocampal neurons. (a) Putative membrane topology of the BKCa channel transcripts. First, they are present at biologically significant ␣-subunit and the location of two sites of alternative splicing (black circles) are levels in the hippocampus, and, more surprisingly, the overall shown. Exons are denoted with vertical solid bars and introns with horizontal complexity of the i16-contiaining transcripts transcript popula- lines. Exon lengths are 69, 12, 87, 77, 9, 174, and 94 nt for e15, e15a, e16, e17, tion is less diverse then would be possible if all combinations of e17a, e17b, and e18, respectively. Intron lengths are 2,340, 6,222, 6,654, 4,528, 6,421, and 30,920 nt for i15, i15a, i16-containing, i17, i17a, and i17b, respec- the downstream exons were associated with the retained intron. tively. KCNMA1 splice variant analysis was performed in hippocampal tissue. These data show the abundance of four KCNMA1 splice variants and the The Subcellular Localization of BKCa Channel and the i16-Containing exonic linkage analysis of each splice variant to i16-containing region.
Recommended publications
  • Foundations of Biophysics and Structural Biology [GMS by 760]
    Foundations of Biophysics And Structural Biology [GMS BY 760] Course Director: David Atkinson Ph.D. Professor of Physiology and Biophysics, Research Professor of Biochemistry Lecturers: Christopher W. Akey Ph.D. Professor of Physiology and Biophysics Olga Gursky Ph.D. Associate Professor of Physiology and Biophysics C. James McKnight Ph.D. Associate Professor of Physiology and Biophysics Michael Rynkiewicz Ph.D. Senior Research Associate in Physiology and Biophysics 1 COURSE INTRODUCTION ( David Atkinson Ph.D.) Lecture I. COURSE OVERVIEW Aims and organization, introduction to faculty, examinations, text books etc. MACROMOLECULAR CONFORMATION AND THE PRINCIPLES OF SYMMETRY Principles of symmetry, symmetry operations, point groups and space groups FOURIER TRANSFORMS (David Atkinson Ph.D.) Lecture I. FOURIER THEORY AND APPLICATION Waves, Fourier series. Fourier and inverse Fourier Transforms. 2 X-RAY DIFFRACTION, SCATTERING AND CRYSTALLOGRAPHY (Lectures I-III, David Atkinson Ph.D.,) (Lectures IV-VII. Michael Rynkiewicz Ph.D.) Lecture I. GEOMETRICAL DIFFRACTION Lattices, Unit Cells, Crystal Systems, Bragg’s Law, the Reciprocal Lattice, Space Groups, von Laue Conditions, Ewald sphere, Lecture II. FOURIER ANALYSIS Convolution and Correlation. Importance in structural biophysics. Lecture III. FOURIER ANALYSIS OF X-RAY SCATTERING AND DIFFRACTION Point scatterers, atomic scattering, form factors, assemblies of scatterers, lattices, electron density, Patterson function, resolution, phases and phase problem, symmetry and systematic absences. Lecture IV. PROTEIN CRYSTALLIZATION Preparing protein samples: Purification, concentrating, storage. Crystal growth: Principles and methods, solubility, saturation, nucleation, batch methods, vapor diffusion methods, dialysis methods, micro and macro seeding. Crystal storage and handling. Crystal soaking: Cryoprotectant, heavy atoms, substrates, ligands or inhibitors. Lecture V. MACROMOLECULAR DATA COLLECTION AND PROCESSING Data collection: Crystal mounting, radiation damage, cryo-techniques.
    [Show full text]
  • Charles Robert Cantor (1942- ) [1]
    Published on The Embryo Project Encyclopedia (https://embryo.asu.edu) Charles Robert Cantor (1942- ) [1] By: Abboud, Alexis Keywords: Sequenom [2] non-invasive prenatal genetic testing [3] Charles Robert Cantor helped sequence the human genome [4], and he developed methods to non-invasively determine the genes [5] in human fetuses. Cantor worked in the US during the twentieth and twenty-first centuries. His early research focused on oligonucleotides, small molecules of DNA or RNA. That research enabled the development of a technique that Cantor subsequently used to describe nucleotide sequences of DNA, a process called sequencing, in humans [6]. Cantor was the principal scientist for the Human Genome Project, for which scientists sequenced the entirety of the human genome [4] in 2003. Afterwards, Cantor became the chief scientific officer for Sequenom Inc., a company that provided non-invasive prenatal genetic testing. Such tests use a pregnant woman's blood to identify genetic mutations in a fetus [7] during the first trimester [8] of pregnancy [9]. Cantor was born on 26 August 1942 to Ida Dianne and Louis Cantor in Brooklyn, New York. As a high school student, he participated in a science program for high school seniors administered by Columbia University [10] in New York, New York. Afterwards, Cantor attended Columbia for his undergraduate degree. While there, Cantor took a course in population genetics taught by Richard Lewontin. Cantor later reported that the course and Lewontin influenced him to pursue biology. Cantor graduated from Columbia in 1963 with his degree. He then pursued doctoral studies in physical chemistry under Ignacio Tinoco Jr.
    [Show full text]
  • OE Human Genome Program Second Contractor-Grantee Workshop (1991)
    .. 1 II !I Acknowledgements I' I The. information for this report was compiled and prepared for publication by Laura Yust and other Human Genome Management Information System staff members. Charles Cantor contributed the I "Santa Fe Workshop Summary" with assistance from Elbert Branscomb, Anthony Carrano, Leroy Hood, Robert Moyzis, Robert Robbins, and DOE program staff. Sylvia Spengler (workshop organizer) and Eileen Mendez at the Lawrence Berkeley Laboratory Human Genome Center provided the abstracts. Most importantly, the contributions of grantees and contractors to the DOE Human Genome Program are gratefully acknowledged. For information or additional copies of this report contact: Laura Yust Human Genome Management Information System Oak Ridge National Laboratory P.O. Box 2008 Oak Ridge, TN 37831-6050 615/574-7582, FrS 624-7582; Fax: 615/574-9888, FTS 624-9888; Internet: "[email protected]"; BITNET: "[email protected]" I I I This report has been reproduced directly from the best available copy. Available from the National Technical Information Service, U.S. Department of Commerce, Springfield, Virginia 22161. I -I Price: Printed Copy A06 II Microfiche AOl l l ' Codes are used for pricing all publications. The code is determined by the number of pages in the publication. Information pertaining to the pricing codes can be found in the current issues of the following publications, which are generally available in most libraries. Energy Research Abstracts, (ERA); Government Reports Announcements and Index (GRA and I); Scientific and Technical Abstract Reports (STAR); and publication, NTIS-PR-360 available from (NTIS) at the above address. Conf-91 02129 Dist: Category UC-408 DOE uman enome Program Report of the Second Contractor-Grantee Workshop February 17-20, 1991 Santa Fe, New Mexico Date Published: August 1991 Prepared for the U.S.
    [Show full text]
  • Report of the 23Rd Asilomar Conference on Mass Spectrometry
    Report of the 23rd Asilomar Conference on Mass Spectrometry Alan L. Rockwood ARUP Laboratories and Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA Ravinder J. Singh Mayo Clinic and Mayo Medical School, Rochester, Minnesota, USA ponsored by ASMS, the 2007 Asilomar conference mor marker) as a model of immunoassay imperfection. “Mass Spectrometry in Clinical Chemistry and Immunoassays are unreliable in some patients due to SMolecular Diagnostics” included 120 participants the presence of auto-antibodies that interfere with the from backgrounds as diverse as industry, instrumenta- test. Hoofnagle’s approach solves the problems of en- tion companies, hospitals, governmental laboratories, dogenous interfering antibodies (digest the sample into reference laboratories, medical schools, and other aca- peptides) and the lack of standardization between dif- demic institutions. The American Association for Clin- ferent commercial immunoassays (include an internal ical Chemistry accredited this conference for ACCENT standard peptide). continuing education credits. Christie Hunter from Applied Biosystems described Following opening comments by organizers Alan in “Peptide MRM-Based Assays in Plasma for Biomar- Rockwood and Ravinder Singh, Jack Henion from Ad- ker Verification Studies,” the use of a triple quadrupole vion Biosciences presented “Can Mass Spectrometry linear ion trap mass spectrometer to create more than Add Value to Modern Clinical Chemistry?” which 1000 high quality, specific MRM transitions for multiple overviewed the merits and issues pertaining to imple- peptides to many human plasma proteins. A non- menting mass spectrometry (especially LC/MS) into isobaric chemical labeling strategy was employed to the modern clinical laboratory. Strengths and limita- create global reference standards to enable quantitative tions of mass spectrometry were described, emphasiz- analysis.
    [Show full text]
  • Boston University Graduate Program in Bioinformatics Handbook 2012
    1 Boston University Graduate Program in Bioinformatics Handbook 2012-2013 http://www.bu.edu/bioinformatics Department of Biochemistry (School of Medicine) Department of Biology (College of Arts and Sciences) Biomedical Engineering Department (College of Engineering) Department of Biostatistics (School of Public Health) Department of Chemistry (College of Arts and Sciences) Department of Computational Biomedicine (School of Medicine) Department of Computer Science (College of Arts and Sciences) Electrical and Computer Engineering Department (College of Engineering) Genetics and Genomics Department (School of Medicine) Department of Mathematics and Statistics (College of Arts and Sciences) Department of Medicine (School of Medicine) Department of Microbiology (School of Medicine) Department of Mechanical Engineering (College of Engineering) Molecular and Cell Biology (Goldman School of Dental Health) Department of Neurology (School of Medicine) Periodontology & Oral Biology (Goldman School of Dental Health) Department of Physics (College of Arts and Sciences) Pulmonary Medicine (School of Medicine) Systems Engineering Division (College of Engineering) Center for Computational Science Center for Advanced Biotechnology Center for Advanced Genomic Technology Last Updated: 10/11/12 2 Bioinformatics Faculty and Staff Faculty Director Thomas Tullius Director of Bioinformatics Associate Directors Gary Benson* Associate Director of IGERT Scott Mohr Administrative Director, Director of Graduate Studies Department of Biochemistry (BUSM) Joseph Zaia Professor Associate Director, Center for Biomedical Mass Spectrometry Department of Biology (CAS) Cynthia Bradham Assistant Professor Geoffrey M. Cooper Professor, Associate Dean of the Faculty, Natural Sciences John Finnerty Associate Professor Ulla Hansen Professor Edward Loechler Professor Kimberly McCall Associate Professor # Daniel Segre* Associate Professor Dean Tolan Professor David Waxman Professor Department of Biomedical Engineering (ENG) Charles Cantor* Professor, Director of Center for Advanced Biotechnology James J.
    [Show full text]
  • 100 Years of Biochemistry at the University of Toronto – Marian A
    Bulletin The Canadian Society of Biochemistry, Molecular & Cellular Biology La Société canadienne de biochemie, de biologie moléculaire et cellulaire ISSN 1197-6578/2007 2007 www.csbmcb.ca Bulletin The Canadian Society of Biochemistry, Molecular & Cellular Biology La Société canadienne de biochemie, de biologie moléculaire et cellulaire 2007 www.csbmcb.ca 2 CSMCB/SCBBMC BULLETIN 2007 FRONT COVER IMAGES: Illustration by Martin Krzywinski, Scientist (Mapping), Canada’s Michael Smith Genome Sciences Centre CSMCB/SCBBMC BULLETIN 2007 3 Contents CSBMCB Board for 2007-2008................................................................................................4 CSBMCB President’s Report...................................................................................................5 Incoming Members of the CSBMCB Executive Board 2006-2007....................................8 Laura Frost, Vice-President; Jean-Pierre Perreault, Councillor; David Williams, Councillor Minutes of the 50th CSBMCB Annual General Meeting ..................................................12 CSBMCB/SCBBMC Financial Statement.............................................................................15 The 50th Annual Meeting of the CSBMCB.........................................................................17 Poster and travel award recipients for the 2007 CSBMCB Meeting .............................19 Scenes from the 2007 CSBMCB Meeting ............................................................................21 Program for the 51st Annual Meeting of the
    [Show full text]
  • THE GENE WARS PT 6.Pdf 7.4 Mb
    Epilogue T I HE JANUARY 1,1993, issue of Science announced that Francis S. JL Collins of the University of Michigan had agreed to direct the NIH genome program,1 confirming rumors that had persisted since midsum- mer. Collins agreed to join NIH on condition that a significant intramural genome research capacity be created on the NIH campus in Bethesda, Mary- land, so he would not have to give up active laboratory work. Collins agreed to make the move despite a cut in pay and the disruption of one of the most secure scientific empires in human genetics. Several members of his group, including himself, were funded by the Howard Hughes Medical Institute. This highly prestigious and financially stable base was buttressed by an NIH- funded genome research center linked to the University of Michigan. The University of Michigan combined one of the best state-supported universities with a medical school that had chosen soon after World War II to emphasize human genetics. Stanford geneticist David Botstein, for one, be- lieved that his unusually broad and deep training at Michigan—with exposure to excellent molecular biology and world-class human genetics, including pop- ulation genetics—gave him the requisite background to prepare him for the 1978 insight about the importance of a human genetic linkage map.2 Con- struction of just such a map helped spawn the revolution in human genetics that began in the 1980s. Why would Collins leave such an enviable position to direct a federal program? His answer: "Because there is only one human genome program. It will only happen once, and this is that moment in history.
    [Show full text]
  • NIH Director's Pioneer Award 2008 Reviewers
    NIH Director’s Pioneer Award 2008 Reviewers Phase 1 James C. Anthony, Ph.D. James Collins, Ph.D. Michigan State University Boston University East Lansing, MI Boston, MA David Baker, Ph.D. William Crowley Jr., M.D. University of Washington Harvard Medical School Seattle, WA Boston, MA Jeffrey Balser, M.D., Ph.D. Roger Detels, M.D. Vanderbilt University Medical Center University of California, Los Angeles Nashville, TN Los Angeles, CA Ben A. Barres, M.D., Ph.D. Jennifer Doudna, Ph.D. Stanford University School of Medicine University of California, Berkeley Stanford, CA Berkeley, CA Jacqueline Barton, Ph.D. Judy Dubno, Ph.D. California Institute of Technology Medical University of South Carolina Pasadena, CA Charleston, SC Leslie Berg, Ph.D. Thomas Earnest, Ph.D. University of Massachusetts Medical Center Lawrence Berkeley National Laboratory Worchester, MA Berkeley, CA Joan Heller Brown, Ph.D. Mostafa El-Sayed, Ph.D. University of California, San Diego Georgia Institute of Technology La Jolla, CA Atlanta, GA Timothy Buchman, M.D., Ph.D. Jennifer Elisseeff, Ph.D. Washington University School of Medicine Johns Hopkins University St. Louis, MO Baltimore, MD Cynthia Burrows, Ph.D. William Fals-Stewart, Ph.D. University of Utah University of Rochester Salt Lake City, UT Rochester, NY Charles Cantor, Ph.D. Marie Filbin, Ph.D. Sequenom, Inc. City University of New York San Diego, CA New York, NY Arup Chakraborty, Ph.D. Claire M. Fraser-Liggett, Ph.D. Massachusetts Institute of Technology University of Maryland Cambridge, MA Baltimore, MD 1 Gary H. Gibbons, M.D. Harry Honig, Ph.D. Morehouse School of Medicine Columbia University Atlanta, GA New York, NY Lila Gierasch, Ph.D.
    [Show full text]
  • Biology for Students: Bioinformatics
    Biology for Students: Bioinformatics The Human Genome Project (HGP) is an international effort to determine the biochemical code for the entire human genome – the base sequences of the 100,000 or so genes and their regulatory elements that serve as the blueprint of human biology. The HGP has generated massive data on genome sequences, disease genes, protein 3-dimensional structures and functions, protein-protein interactions, and gene regulation. Bioinformatics is a new field centered on the development and application of computational methods to organize, integrate and analyze these data. It is closely tied to two other nascent fields – genomics (identification and functional characterization of genes in a massively parallel and high throughput fashion) and proteomics (analysis of the biological functions of gene products and their interactions), which have also resulted from the HGP. The HGP will have major impacts on understanding evolution and developmental biology, and our ability to diagnose and treat diseases. Its impact is also being felt in areas outside those of traditional biology, such as anthropology and forensic medicine. In 1985, a group of visionary scientists led by Charles DeLisi, who was then the director of the office of health and environmental research at the U.S. Department of Energy (DOE), realized that having the entire human genome in hand would provide the foundation for a revolution in biology and medicine (DeLisi, 1988, p.488). As a result, the 1988 presidential budget submission to Congress requested funds to start the Human Genome Project. Momentum built quickly and by 1990 DOE and the U.S. National Institutes of Health (NIH) had coordinated their plans for a fifteen-year project (Collins and Gallas, 1993, p.43).
    [Show full text]
  • Synthetic Biology - Mapping the Patent Landscape Paul Oldham 1,2 Stephen Hall 3 1
    bioRxiv preprint doi: https://doi.org/10.1101/483826; this version posted November 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Synthetic Biology - Mapping the Patent Landscape Paul Oldham 1,2 Stephen Hall 3 1. Industrial Fellow, Manchester Institute of Innovation Research, Alliance Manchester Business School, Manchester University. 2 Senior Visiting Fellow, Institute for the Advanced Study of Sustainability, United Nations University 3. Information System Services, Lancaster University Abstract This article presents the global patent landscape for synthetic biology as a new and emerging area of science and technology. The aim of the article is to provide an overview of the emergence of synthetic biology in the patent system and to contribute to future research by providing a high quality tagged core dataset with 7,424 first filings and 71,887 family members. This dataset is intended to assist with evidence based exploration of synthetic biology in the patent system and with advancing methods for the analysis of new and emerging areas of science and technology. The starting point for the research is recognition that traditional methods of patent landscape analysis based on key word searches face limitations when addressing new and emerging areas of science and technology. Synthetic biology can be broadly described as involving the design, synthesis and assembly of biological parts, circuits, pathways, cells and genomes. As such synthetic biology can be understood as emerging from a combination of overlaps and convergences between existing fields and disciplines, such as biotechnology, genetic engineering, protein engineering and systems biology.
    [Show full text]
  • Pnas11052ackreviewers 5098..5136
    Acknowledgment of Reviewers, 2013 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2013. Their generous contribution is deeply appreciated. A Harald Ade Takaaki Akaike Heather Allen Ariel Amir Scott Aaronson Karen Adelman Katerina Akassoglou Icarus Allen Ido Amit Stuart Aaronson Zach Adelman Arne Akbar John Allen Angelika Amon Adam Abate Pia Adelroth Erol Akcay Karen Allen Hubert Amrein Abul Abbas David Adelson Mark Akeson Lisa Allen Serge Amselem Tarek Abbas Alan Aderem Anna Akhmanova Nicola Allen Derk Amsen Jonathan Abbatt Neil Adger Shizuo Akira Paul Allen Esther Amstad Shahal Abbo Noam Adir Ramesh Akkina Philip Allen I. Jonathan Amster Patrick Abbot Jess Adkins Klaus Aktories Toby Allen Ronald Amundson Albert Abbott Elizabeth Adkins-Regan Muhammad Alam James Allison Katrin Amunts Geoff Abbott Roee Admon Eric Alani Mead Allison Myron Amusia Larry Abbott Walter Adriani Pietro Alano Isabel Allona Gynheung An Nicholas Abbott Ruedi Aebersold Cedric Alaux Robin Allshire Zhiqiang An Rasha Abdel Rahman Ueli Aebi Maher Alayyoubi Abigail Allwood Ranjit Anand Zalfa Abdel-Malek Martin Aeschlimann Richard Alba Julian Allwood Beau Ances Minori Abe Ruslan Afasizhev Salim Al-Babili Eric Alm David Andelman Kathryn Abel Markus Affolter Salvatore Albani Benjamin Alman John Anderies Asa Abeliovich Dritan Agalliu Silas Alben Steven Almo Gregor Anderluh John Aber David Agard Mark Alber Douglas Almond Bogi Andersen Geoff Abers Aneel Aggarwal Reka Albert Genevieve Almouzni George Andersen Rohan Abeyaratne Anurag Agrawal R. Craig Albertson Noga Alon Gregers Andersen Susan Abmayr Arun Agrawal Roy Alcalay Uri Alon Ken Andersen Ehab Abouheif Paul Agris Antonio Alcami Claudio Alonso Olaf Andersen Soman Abraham H.
    [Show full text]
  • Genomic Technology, Boston University, Boston, MA 02215
    Triplet repeat length bias and variation in the human transcriptome Michael Mollaa,1,2, Arthur Delcherb,1, Shamil Sunyaevc, Charles Cantora,d,2, and Simon Kasifa,e aDepartment of Biomedical Engineering and dCenter for Advanced Biotechnology, Boston University, Boston, MA 02215; bCenter for Bioinformatics and Computational Biology, University of Maryland, College Park, MD 20742; cDepartment of Medicine, Division of Genetics, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; and eCenter for Advanced Genomic Technology, Boston University, Boston, MA 02215 Contributed by Charles Cantor, July 6, 2009 (sent for review May 4, 2009) Length variation in short tandem repeats (STRs) is an important family including Huntington’s disease (10) and hereditary ataxias (11, 12). of DNA polymorphisms with numerous applications in genetics, All Huntington’s patients exhibit an expanded number of copies in medicine, forensics, and evolutionary analysis. Several major diseases the CAG tandem repeat subsequence in the N terminus of the have been associated with length variation of trinucleotide (triplet) huntingtin gene. Moreover, an increase in the repeat length is repeats including Huntington’s disease, hereditary ataxias and spi- anti-correlated to the onset age of the disease (13). Multiple other nobulbar muscular atrophy. Using the reference human genome, we diseases have also been associated with copy number variation of have catalogued all triplet repeats in genic regions. This data revealed tandem repeats (8, 14). Researchers have hypothesized that inap- a bias in noncoding DNA repeat lengths. It also enabled a survey of propriate repeat variation in coding regions could result in toxicity, repeat-length polymorphisms (RLPs) in human genomes and a com- incorrect folding, or aggregation of a protein.
    [Show full text]